120 related articles for article (PubMed ID: 18479919)
1. Synthesis and evaluation of heteroaromatic 6,7-diaryl-2,3,8,8a-tetrahydroindolizin-5(1H)-ones for cytotoxicity against the HCT-116 colon cancer cell line.
Kimball FS; Himes RH; Georg GI
Bioorg Med Chem Lett; 2008 Jun; 18(11):3248-50. PubMed ID: 18479919
[TBL] [Abstract][Full Text] [Related]
2. Enantiospecific synthesis and cytotoxicity of 7-(4-methoxyphenyl)-6-phenyl-2,3,8,8a-tetrahydroindolizin-5(1H)-one enantiomers.
Kimball FS; Turunen BJ; Ellis KC; Himes RH; Georg GI
Bioorg Med Chem; 2008 Apr; 16(8):4367-77. PubMed ID: 18343127
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro and in vivo cytotoxicity of 6,7-diaryl-2,3,8,8a-tetrahydroindolizin-5(1H)-ones.
Kimball FS; Tunoori AR; Victory SF; Dutta D; White JM; Himes RH; Georg GI
Bioorg Med Chem Lett; 2007 Aug; 17(16):4703-7. PubMed ID: 17614274
[TBL] [Abstract][Full Text] [Related]
4. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
5. Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents.
Sharma VM; Adi Seshu KV; Vamsee Krishna C; Prasanna P; Chandra Sekhar V; Venkateswarlu A; Rajagopal S; Ajaykumar R; Deevi DS; Rao Mamidi NV; Rajagopalan R
Bioorg Med Chem Lett; 2003 May; 13(10):1679-82. PubMed ID: 12729640
[TBL] [Abstract][Full Text] [Related]
6. Selective recognition of DNA parallel G-quadruplexes by 3,8a-disubstituted indolizinones.
Zhang JT; Wang LX; Yang FM; Yang L; Liu Y; Tang YL
Bioorg Med Chem; 2021 Jan; 29():115848. PubMed ID: 33189508
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and bioevaluation of 22-hydroxyacuminatine analogs.
Grillet F; Baumlová B; Prévost G; Constant JF; Chaumeron S; Bigg DC; Greene AE; Kanazawa A
Bioorg Med Chem Lett; 2008 Mar; 18(6):2143-6. PubMed ID: 18276141
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
13. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological screening of new thiazolo[4,5-d]pyrimidine and dithiazolo[3,2-a:5',4'-e]pyrimidinone derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
Abd Elhameed AA; El-Gohary NS; El-Bendary ER; Shaaban MI; Bayomi SM
Bioorg Chem; 2018 Dec; 81():299-310. PubMed ID: 30172111
[TBL] [Abstract][Full Text] [Related]
19. Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
Yang X; Shi Q; Liu YN; Zhao G; Bastow KF; Lin JC; Yang SC; Yang PC; Lee KH
J Med Chem; 2009 Aug; 52(16):5262-8. PubMed ID: 19645447
[TBL] [Abstract][Full Text] [Related]
20. First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of alpha- and beta-peltatin.
Couture A; Deniau E; Grandclaudon P; Lebrun S; Léonce S; Renard P; Pfeiffer B
Bioorg Med Chem; 2000 Aug; 8(8):2113-25. PubMed ID: 11003157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
